What Mirum Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 10 | 59 |
| Total trades | 17 | 108 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 136,642 | 907,086 |
| Disposed | 108,442 | 487,746 |
| Net activity | +28,200 | +419,340 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Oct 16 | Exercise / conversion · M | +16,112 | $19.24 | +$310K | 16,728 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Oct 06 | Exercise / conversion · M | +6,892 | $15.87 | +$109K | 206,637 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Oct 06 | Exercise / conversion · M | +5,305 | $19.19 | +$102K | 199,745 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Sep 14 | Open-market sale · S | −9,943 | $98.37 | −$978K | 44,745 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Sep 11 | Exercise / conversion · M | +18,333 | — | — | 54,688 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sep 02 | Open-market sale · S | −658 | $100.00 | −$65.8K | 616 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sep 01 | Open-market sale · S | −21,688 | $98.91 | −$2.15M | 194,440 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sep 01 | Open-market sale · S | −8,312 | $98.08 | −$815K | 216,128 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sep 01 | Exercise / conversion · M | +30,000 | $2.94 | +$88.1K | 224,440 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Aug 18 | Open-market sale · S | −40,000 | $100.00 | −$4M | 1,274 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Aug 18 | Exercise / conversion · M | +40,000 | $6.27 | +$251K | 41,274 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Aug 11 | Open-market sale · S | −6,001 | $99.90 | −$600K | 36,355 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Aug 10 | Open-market sale · S | −2,300 | $100.14 | −$230K | 194,309 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Aug 10 | Open-market sale · S | −6,017 | $99.25 | −$597K | 196,609 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Aug 10 | Open-market sale · S | −11,683 | $98.51 | −$1.15M | 202,626 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Aug 10 | Exercise / conversion · M | +20,000 | $2.94 | +$58.7K | 214,309 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Aug 03 | Open-market sale · S | −1,840 | $105.29 | −$194K | 1,274 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Jul 06 | Open-market sale · S | −300 | $124.94 | −$37.5K | 42,181 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Jul 06 | Open-market sale · S | −528 | $123.84 | −$65.4K | 42,481 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Jul 06 | Open-market sale · S | −1,048 | $122.43 | −$128K | 43,009 |
Loading...